All results

8 results for congenital heart disease

• Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder

  The main objective of the study is to assess the effect of treprostinil palmitil inhalation powder (TPIP) compared with placebo on pulmonary vascular…

  Ages

  18 Years - 75 Years

  Sexes

  All

• HEAL-IST

  Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality…

  Ages

  18 Years - 75 Years

  Sexes

  All

• REBIRTH

  The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of…

  Ages

  18 Years - N/A

  Sexes

  Female

• Trial of DCA in PDCD

  The objective of this research study is to conduct a pivotal phase 3 trial of treatment with the investigational drug dichloroacetate (DCA) in young children…

  Ages

  6 Months - 17 Years

  Sexes

  All

• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  In parallel with the growth of American Thrombosis and Hemostasis Network's (ATHN) clinical studies, the number of new therapies for all congenital and…

  Ages

  N/A - N/A

  Sexes

  All

• TRYP-001

  To better understand the potential benefits of psychedelics in overeating disorders, Tryp Therapeutics will conduct a safety and feasibility clinical trial…

  Ages

  18 Years - 64 Years

  Sexes

  All

• Immunotherapy for Patients With Advanced Kidney Cancer, The PDIGREE Study

  This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and…

  Ages

  18 Years - N/A

  Sexes

  All

• ReCePI

  The objective of this study is to evaluate the efficacy and safety of RBC transfusion for support of acute anemia in cardiovascular surgery patients based on…

  Ages

  11 Years - N/A

  Sexes

  All